Medicare Test Co-Pays Would Add To Labs’ Overhead; Firms Brace For Impact
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic testing firms' profitability could suffer along with patient access to care if a laboratory diagnostic co-payment provision is included in pending Medicare reform legislation, stakeholders say
You may also be interested in...
Labs, Test Makers To Finance Committee: Say "No" To Medicare Co-Pay
Clinical laboratory stakeholders are trying to prevent a 20% Medicare lab co-payment provision from making it into the Senate Finance Committee's highly anticipated health care reform package
Labs, Test Makers To Finance Committee: Say "No" To Medicare Co-Pay
Clinical laboratory stakeholders are trying to prevent a 20% Medicare lab co-payment provision from making it into the Senate Finance Committee's highly anticipated health care reform package
Lab Co-Pay Provision Dropped From Medicare Package In Favor Of Freeze
Laboratory advocacy groups are mobilizing to oppose a seven-to-ten-year freeze on the clinical laboratory fee schedule proposed after Congressional conferees opted to drop a lab co-payment provision from the final Medicare package